期刊文献+

腹腔化疗和静脉化疗对胃肠道癌术后患者免疫功能的影响 被引量:5

Effect on the Immunity of Postoperative Gastrointestinal Carcinoma in Patients with Intraperitoneal Chemotherapy Versus Intravenous Chemotherapy
暂未订购
导出
摘要 目的 :比较腹腔化疗和静脉化疗对胃肠道癌术后患者免疫功能的影响。方法 :40例胃肠道癌患者随机分为两组 ,每组 2 0例 ,一组接受腹腔化疗 ,另一组接受静脉化疗 ,检测化疗前后患者血清中 T细胞亚群和 s IL- 2 R水平。结果 :化疗后血清 CD3、CD4和 s IL- 2 R水平较化疗前明显下降 ,两组间 CD3、CD4、CD8变化无显著差异 ,腹腔化疗组化疗后血清 s IL - 2 R水平显著低于静脉化疗组。结论 :腹腔化疗比静脉化疗对机体免疫的影响小 ,提倡腹腔化疗。 Objective:To compare the effect of postoperative intraperitoneal chemotherapy (PIC) on the immunity of gastrointestinal carcinoma (GC) patients with that of intravenous chemotherapy (IVC). Methods:40 patients were divided into two groups,one group received PIC and the other received IVC. The serum T lymphocyte subsets (T LS) and sIL 2R level before and after the chemotherapy were determined.Results:Serum CD 3,CD 4 and sIL 2R in GC patients were significantly decreased after the chemotherapy,however serum CD 3,CD 4,CD 8 levels were similar between PIC and IVC.Mean sIL 2R level in PIC group was lower than that in IVC.Conclusion:PIC affects the immunity more moderate than IVC dose and should be recommended as possible.
出处 《华夏医学》 2001年第4期413-414,共2页 Acta Medicinae Sinica
关键词 免疫 腹腔化疗 静脉化疗 胃肿瘤 肠肿瘤 carcinoma gastrointestine chemotherapy immunity
  • 相关文献

参考文献10

  • 1[1]Cunliffe WJ,Sujarbaker TH.Gastrointestinal malignancy rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy[J].Br J surg, 1989,76(10):1082-1090.
  • 2冉江华,张家骅,郭群,王曦.腹腔热化疗对胃肠道恶性肿瘤患者T淋巴细胞亚群及sIL-2R水平的影响[J].中国普外基础与临床杂志,1999,6(3):156-157. 被引量:5
  • 3[3]Murakami S, Satomi A,Ishidek,et al.Serum soluble interleukin-2 receptor in colorectal cancer[J]. Acta Oncol,1994,33(1):19-21.
  • 4[4]Jacques Y, Lemauff B,Boeffard F,et al. A soluble interleukin-2 receptor produced by anormal alloreative human T Cell clonesbinds interleukin with low affinity[J].J Immunol,1987,139:2308.
  • 5[5]Laurence A, Kataoka T,Gary M,et al. The solube interleukin-2 receptor biology,function and clinic application[J].Ann Inter Med, 1990,113(8):619.
  • 6[6]Jan Zaloudik, Icim NW. Significance of pre-treatment Immunological Parameters in Colorectal Cancer Patiens with Unresectable Metastases to the liver[J].Hepato-Gastroenterlogy, 1999,46:220-227.
  • 7[7]Lissoni P, Andus T,Eason JD,et al.Effects of cancer chemotherapy on the re1ation between serum levels of solube interleukin-2 receptor and cd4/cd8 ratio in patients with solid neoplasms[J].J Biol Regul Homeost Agents,1989,3(3):131-133.
  • 8[8]Fujimoto S, Takahashi M,Mutou T,et al.Sucessful Intraperitoneal Hyperthermic chemoperfusion for the Prevention of postoperative peritoneal Recurrence in patients with Advanced Gastric Carcinoma[J].Cancer,1999,85(3):529-534.
  • 9花亚伟,张鉴哲,李天心,孔烨,孔永霞,朱燕.腹腔免疫化疗预防胃癌术后腹腔复发的临床研究[J].中国实用外科杂志,1999,19(6):358-359. 被引量:17
  • 10[10]Wansik Yu,Whang I,Fuho I,et al.Prospective Randomized Trial of Early Postoperative Intraperitoneal chemotherapy as an Adjuvant to Resectable Gastric Cancer[J].Ann Surg,1998,228(3):347-354.

二级参考文献12

共引文献20

同被引文献16

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部